Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment

Voriconazole plasma concentrations (PC) are highly variable, particularly in children. Dose recommendations in 2–12-year-old patients changed in 2012. Little data on therapeutic drug monitoring (TDM) after these new recommendations are available. We aimed to evaluate voriconazole monitoring in child...

Descripción completa

Detalles Bibliográficos
Autores principales: Valle-T-Figueras, José María, Renedo Miró, Berta, Benítez Carabante, Maria Isabel, Díaz-de-Heredia, Cristina, Vima Bofarull, Jaume, Mendoza-Palomar, Natalia, Martín-Gómez, Maria Teresa, Soler-Palacín, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227726/
https://www.ncbi.nlm.nih.gov/pubmed/34200506
http://dx.doi.org/10.3390/jof7060456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227726/
https://www.ncbi.nlm.nih.gov/pubmed/34200506
http://dx.doi.org/10.3390/jof7060456

Ejemplares similares